Cargando…

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?

IgA nephropathy (IgAN) is characterized by a variable clinical course and multifaceted pathophysiology. There is substantial evidence to suggest that complement activation plays a pivotal role in the pathogenesis of the disease. Therefore, complement inhibition using the humanized anti-C5 monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ring, Troels, Pedersen, Birgitte Bang, Salkus, Giedrius, Goodship, Timothy H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581393/
https://www.ncbi.nlm.nih.gov/pubmed/26413271
http://dx.doi.org/10.1093/ckj/sfv076